GGrantIndex
Sort

78,016 grants matching breast cancer

Genomic Biology of the Tandem Duplicator Phenotype in Mouse and Human Cancers

$703,993
Edison Tak-Bun Liu · Jackson Laboratory · R01 · FY2025 · CA

Brain Tumors - Immunological and Biological Studies

$703,967
Darell D Bigner · Duke University · R37 · FY2010 · CA

Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers

$703,749
Joellen M. Schildkraut · University Of Virginia · R01 · FY2018 · CA

Chemistry and Biology of Platinum Anticancer Drugs

$703,653
Stephen J Lippard · Massachusetts Institute Of Technology · R01 · FY2010 · CA

Mapping Genes for Mammographic Breast Density

$703,640
Julie A. Douglas · University Of Michigan At Ann Arbor · R01 · FY2009 · CA

PENN RCMAR

$703,617
Jerry Calvin Johnson · University Of Pennsylvania · P30 · FY2011 · AG

Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer

$703,616
Faraz Bishehsari · Rush University Medical Center · R01 · FY2023 · CA

Mechanistic studies of hirsutinolides and azetidine-based small molecule inhibitors of STAT3

$703,595
James K Turkson · Cedars-Sinai Medical Center · R01 · FY2024 · CA

Development and optimization of highly effective treatments in patients with head and neck cancer using in situ implantable microdevices

$703,540
Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2025 · CA

A prospective study of circulating autoantibodies and breast cancer risk in the NYU Women’s Health Study

$703,423
Yu Chen · New York University School Of Medicine · U01 · FY2025 · CA

Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1

$703,389
Jane Amanda Skok · New York University School Of Medicine · R01 · FY2025 · CA

Retinoic Acid Induced Lymphangiogenesis for Post-surgical Lymphedema

$703,342
Alex K. Wong · Beckman Research Institute/City Of Hope · R01 · FY2023 · HL

Machine learning for risk-adjusted breast MRI screening

$703,284
Lucas C Parra · City College Of New York · R01 · FY2021 · CA

Multinuclear MRI to Monitor Breast Cancer Therapy

$703,220
Guillaume Madelin · New York University School Of Medicine · R01 · FY2023 · CA

Early Detection of Breast Cancer Using Autoantibody Mar*

$703,194
Michael A Tainsky · Wayne State University · U01 · FY2008 · CA

Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer

$703,149
Lorenzo Galluzzi · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

MOUSE CANCER MODELS BY REGULATED INACTIVATION OF TUMOR S

$703,046
University Of California Irvine · U01 · FY2002 · CA

SALSA - Study of Active Lifestyle Activation

$703,031
Eric Jessen Chow · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Telomeres and lung cancer incidence and survival

$703,025
Jennifer A. Doherty · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA

Feasibility and Assessment of a Cascade Traceback Screening program - FACTS

$703,016
Alanna K Rahm · Geisinger Clinic · U01 · FY2020 · CA

Dana-Farber/Harvard SPORE in Breast Cancer

$703,004
James Dirk Iglehart · Dana-Farber Cancer Inst · P50 · FY2006 · CA

Urban Latino African American Cancer Disparities Project

$702,985
Michael Lee Steinberg · Daniel Freeman Memorial Hospital · U56 · FY2006 · CA

Three-Arm randomized trial comparing the effect of aspirin, sulindac or no treatment control on breast density in patients with elevated breast cancer risk

$702,967
Patricia Ann Thompson-Carino · State University New York Stony Brook · R01 · FY2023 · CA

Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans

$702,828
Leif W Ellisen · Massachusetts General Hospital · R01 · FY2023 · CA

Determining the role of neutrophils in anti-tumor immunity and immune-related adverse events in the context of T cell-based therapies

$702,748
Taha Merghoub · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA